Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells (Q22009110)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells	scientific article

Statements

scholarly article

0 references

Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

G Xiao

1

author given names

G

author last names

Xiao

1 reference

PubMed publication ID

6 February 2023

Y E Liu

2

author given names

Y E

author last names

Liu

1 reference

PubMed publication ID

6 February 2023

R Gentz

3

author given names

R

author last names

Gentz

1 reference

PubMed publication ID

6 February 2023

Q A Sang

4

author given names

Q A

author last names

Sang

1 reference

PubMed publication ID

6 February 2023

J Ni

5

author given names

J

author last names

Ni

1 reference

PubMed publication ID

6 February 2023

I D Goldberg

6

author given names

I D

author last names

Goldberg

1 reference

PubMed publication ID

6 February 2023

Y E Shi

7

author given names

Y E

author last names

Shi

1 reference

PubMed publication ID

6 February 2023

language of work or name

0 references

publication date

30 March 1999

0 references

Proceedings of the National Academy of Sciences of the United States of America

0 references

96

0 references

7

0 references

3700-5

0 references

Basic local alignment search tool

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

19 March 2017

Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

19 March 2017

Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

19 March 2017

Complementary DNA sequencing: expressed sequence tags and human genome project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

7 April 2017

Plasminogen activator inhibitor type 2 in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Purification, cDNA cloning, and characterization of a new serpin with megakaryocyte maturation activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

27 September 2017

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

27 September 2017

Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

27 September 2017

Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

27 September 2017

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Differentiation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.96.7.3700

21 January 2018

Incidence of and treatment for ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.96.7.3700

21 January 2018

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

29 November 2018

Plasminogen activator system in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Function of maspin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The myoepithelial defense: a host defense against cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteases as prognostic markers in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.96.7.3700

0 references

1999PNAS...96.3700X

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22009110&oldid=1827986850"